67
Views
70
CrossRef citations to date
0
Altmetric
Research Article

Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients

, &
Pages 991-995 | Published online: 08 Jul 2009

  • Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980:79:200-6.
  • Chapman RWG, Arborgh BAM, Rhodes JM, Summerfield JA, Dick R, Scheuer P, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980:21:870-7.
  • Schrumpf E, Elgjo K, Fausa O, Gjone E, Kolmannskog F, Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 1980:15:689-97.
  • Wiesner RH. Diagnostic criteria, clinical manifestations and natural history of primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases, 2nd edn. Amsterdam: Elsevier Science B.V.; 1998. p. 381-412.
  • Boherg KM, Lundin KEA, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol 1994:29 Suppl 204:47-58.
  • Mitchell S, Chapman RW. The pathogenesis of primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases, 2nd edn. Amsterdam: Elsevier Science B.V.: 1998. p. 71-101.
  • Spurkland A, Saarinen S, Boherg KM, Mitchell S, Broomé U, Caballeria L, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 1999:53:459-69.
  • Donaldson PT, Albertini RJ, Krawitt EL. Immunogenetic studies in autoimmune hepatitis and primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases, 2nd edn. Amsterdam: Elsevier Science B.V.; 1998. p. 141-65.
  • Boherg KM, Schrumpf E. Treatment of primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases, 2nd edn. Amsterdam: Elsevier Science B.V.; 1998. p. 529-51.
  • Mitchell SA, Chapman RWG. Review article: the management of primary sclerosing cholangitis. Aliment Pharmacol Ther 1997:11:33-43.
  • Lindor KD, the Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997:336:691-5.
  • Moloney M, Williams R. The results of liver transplantation in autoimmune liver disease. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases, 2nd edn. Amsterdam: Elsevier Science B.V.; 1998. p. 553-70.
  • Myers RN, Cooper JH, Padis N. Primary sclerosing cholangitis. Complete gross and histologie reversal after long-term steroid therapy. Am J Gastroenterol 1970:53:527-38.
  • Lindor KD, Wiesner RH, Colwell LJ, Steiner B, Beaver S, LaRusso NF. The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991:85:57-61.
  • Burgert SL, Brown BP, Kirkpatrick RB, LaBrecque DR. Positive corticosteroid response in early primary sclerosing cholangitis [abstract]. Gastroenterology 1984:86:1037.
  • van Buuren HR, van Hoogstraten HJF, Terkivatan T, Schalm SW, Vleggar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000:33:543-8.
  • McNair ANB, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 1998:93: 777-84.
  • Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998:28:360-5.
  • Schramm C, Schirmacher P, Helmreich-Becker I, Gerker G, Meyer zum Buschenfelde KH, Lohse AW. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series. Ann Intern Med 1999:131:943-6.
  • van Hoogstraten HJF, Vleggar FP, Boland GJ, van Steenbergen W, Griffioen P, Hop WCJ, et al. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Am J Gastroenterol 2000:95:2015-22.
  • Boberg KM, Fausa O, Haaland T, Holler E, Mellbye OJ, Spurkland A, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis. An evaluation of 1 14 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996:23:1369-76.
  • Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991:11:31-9.
  • Johnson PJ, McFarlane IG. Meeting report: International autoimmune hepatitis group. Hepatology 1993:18:998-1005.
  • International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-38.
  • Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
  • Bjøro K, Frimann S, Höckerstedt K, Kirkegaard P, Keiding S, Schrumpf E, et al. Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol 1999:34:714-22.
  • Angulo P, Batts KP, Jorgensen RA, LaRusso NA, Lindor KD. Oral budesonide in the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000:95:2333-7.
  • Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RAF, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991:14:257-61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.